1Lefebvre J, Chevalier D, Luboinski B, et al, Larynx preservation in pyriform sinus cancer:preliminary results of a European Organization for Research and Treatment of Cancer phase Ⅲ trial[J]. J Nat Cancer Inst, 1996,88( 13 ) :890 - 898.
2Calais G, Alfonsi M, Bardet E, et ai. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma[ J ]. J Natl Cancer Inst, 1999, 91 (24) :2 081 -2 086.
3Glabbeke M,Van Oosterom AT,Christian MC,et al. New guidelines to evaluate the response to treatment in solid tumor[J]. J Natl Cancer lnst ,2000,92 (3) :205 - 216.
4Monnrat C,Faivre S,Temam S,et al, End points for new agents in induction chemotherapy for locally advanced head and neck cancers [J]. Ann Oncol,2002,13 (17) :995 -1 006.
6Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data-MACH-NC Collaborative Group: meta-analysis of chemotherapy on head and neck cancer [J]. Lancet,2000,355 (9 208) :949 -955.
7Domenge C, Hill C, Lefebvre J,et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma [ J ]. Br J Cancer,2000,83 (12) :1 594-1 598.
8Vokes EE,Stenson K,Rosen FR,et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemotherapy:curative and organ-preseving therapy for advanced head and neck cancer[ J]. J Clin Oncol,2003,21 (2) :320-326.
9Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer [J]. N Engl J Med,2003,349(22) :2 091 -2 098.
1Mariette C, Seitz JF, Maihard E, et al. Surgery alone versus che- moradio"followed by surgery for localized esophageal cancer: a- nalysis of a randomized controlled phase Ill trial FFCD9901. Proc Am Soc Clin Oncol,2010,28( 11 ) :4005.
